Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma

J Clin Oncol. 2012 Feb 20;30(6):e76-8. doi: 10.1200/JCO.2011.38.7886. Epub 2011 Dec 27.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents / adverse effects
  • Female
  • Humans
  • Ipilimumab
  • Melanoma / drug therapy*
  • Middle Aged
  • Posterior Leukoencephalopathy Syndrome / chemically induced*
  • Posterior Leukoencephalopathy Syndrome / diagnosis
  • Skin Neoplasms / drug therapy*
  • Vaginal Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Ipilimumab